<VariationArchive VariationID="431701" VariationName="NM_000533.5(PLP1):c.384_393del (p.Gln129fs)" VariationType="Deletion" Accession="VCV000431701" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-14" DateCreated="2018-06-01" MostRecentSubmission="2018-06-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="425233" VariationID="431701">
      <GeneList>
        <Gene Symbol="PLP1" FullName="proteolipid protein 1" GeneID="5354" HGNC_ID="HGNC:9086" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776506" stop="103792619" display_start="103776506" display_stop="103792619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103031438" stop="103047547" display_start="103031438" display_stop="103047547" Strand="+" />
          </Location>
          <OMIM>300401</OMIM>
          <Haploinsufficiency last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
        <Gene Symbol="RAB9B" FullName="RAB9B, member RAS oncogene family" GeneID="51209" HGNC_ID="HGNC:14090" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776324" stop="103832257" display_start="103776324" display_stop="103832257" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103077254" stop="103087211" display_start="103077254" display_stop="103087211" Strand="-" />
          </Location>
          <OMIM>300285</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000533.5(PLP1):c.384_393del (p.Gln129fs)</Name>
      <CanonicalSPDI>NC_000023.11:103786656:CCAACATCAA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103786657" stop="103786666" display_start="103786657" display_stop="103786666" variantLength="10" positionVCF="103786656" referenceAlleleVCF="GCCAACATCAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103041586" stop="103041595" display_start="103041586" display_stop="103041595" variantLength="10" positionVCF="103041585" referenceAlleleVCF="GCCAACATCAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Q129fs</ProteinChange>
      <ProteinChange>Q74fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000533.5" sequenceAccession="NM_000533" sequenceVersion="5" change="c.384_393del" MANESelect="true">
            <Expression>NM_000533.5:c.384_393del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000524.3" sequenceAccession="NP_000524" sequenceVersion="3" change="p.Gln129fs">
            <Expression>NP_000524.3:p.Gln129fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128834.3" sequenceAccession="NM_001128834" sequenceVersion="3" change="c.384_393del">
            <Expression>NM_001128834.3:c.384_393del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001122306.1" sequenceAccession="NP_001122306" sequenceVersion="1" change="p.Gln129fs">
            <Expression>NP_001122306.1:p.Gln129fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001305004.1" sequenceAccession="NM_001305004" sequenceVersion="1" change="c.219_228del">
            <Expression>NM_001305004.1:c.219_228del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001291933.1" sequenceAccession="NP_001291933" sequenceVersion="1" change="p.Gln74fs">
            <Expression>NP_001291933.1:p.Gln74fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199478.3" sequenceAccession="NM_199478" sequenceVersion="3" change="c.348+36_348+45del">
            <Expression>NM_199478.3:c.348+36_348+45del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.103041586_103041595del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.103041586_103041595del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.103786657_103786666del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.103786657_103786666del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008863.2" sequenceAccession="NG_008863" sequenceVersion="2" change="g.15147_15156del">
            <Expression>NG_008863.2:g.15147_15156del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016452.2" sequenceAccession="NG_016452" sequenceVersion="2" change="g.50617_50626del">
            <Expression>NG_016452.2:g.50617_50626del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799832" DB="ClinGen" />
        <XRef Type="rs" ID="1556267215" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000533.5(PLP1):c.384_393del (p.Gln129fs) AND Pelizaeus-Merzbacher disease" Accession="RCV000655935" Version="1">
        <ClassifiedConditionList TraitSetID="3066">
          <ClassifiedCondition DB="MedGen" ID="C0205711">Pelizaeus-Merzbacher disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-06-01" MostRecentSubmission="2018-06-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3066" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3286" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Sudanophilic leukodystrophy</ElementValue>
                <XRef ID="HP:0003269" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pelizaeus-Merzbacher disease</ElementValue>
                <XRef ID="Pelizaeus-Merzbacher+disease/5643" DB="Genetic Alliance" />
                <XRef ID="64855000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pelizaeus Merzbacher brain sclerosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pelizeaus-Merzbacher spectrum disorder</ElementValue>
                <XRef ID="MONDO:0010714" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PMD</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PLP1-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLP1 disorders of central nervous system myelin formation include a range of phenotypes from Pelizaeus-Merzbacher disease (PMD) to spastic paraplegia 2 (SPG2). PMD typically manifests in infancy or early childhood with nystagmus, hypotonia, and cognitive impairment; the findings progress to severe spasticity and ataxia. Life span is shortened. SPG2 manifests as spastic paraparesis with or without CNS involvement and usually normal life span. Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families. Heterozygous females may manifest mild-to-moderate signs of the disease.</Attribute>
                <XRef ID="NBK1182" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4265" />
                <XRef ID="4265" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301361</ID>
                <ID Source="BookShelf">NBK1182</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="702" DB="Orphanet" />
              <XRef ID="C0205711" DB="MedGen" />
              <XRef ID="MONDO:0010714" DB="MONDO" />
              <XRef Type="MIM" ID="312080" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003269" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1142491" SubmissionDate="2017-08-04" DateLastUpdated="2018-06-01" DateCreated="2018-06-01">
        <ClinVarSubmissionID localKey="ACP3_PLP1|OMIM:312080" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000586817" DateUpdated="2018-06-01" DateCreated="2018-06-01" Type="SCV" Version="1" SubmitterName="TIDEX, University of British Columbia" OrgID="506168" OrganizationCategory="clinic" OrgAbbreviation="TIDEX" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" alternateAllele="TCCA" referenceAllele="TCCAGAGGCCAACA" start="103041582" stop="103041595" variantLength="14" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128834.1:c.384_393del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="312080" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2628449</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1142491" TraitType="Disease" MappingType="XRef" MappingValue="312080" MappingRef="OMIM">
        <MedGen CUI="C0205711" Name="Pelizaeus-Merzbacher disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

